Earlier in 2025, the same research group published papers demonstrating that although GLP-1 drugs deliver impressive long-term health improvements, their prices far exceeded accepted thresholds for cost-effectiveness
17 Bu rnler, etken madde iermeme, farkl maddelerle (rnein inslin) kartrlma veya uygunsuz sterilizasyon gibi nedenlerle kullanclar asndan ciddi salk riskleri oluturabilir
Hypoglycemia is another potential cause of lightheadedness, especially when tirzepatide is combined with other glucose-lowering medications
In certain cases where a more limited treatment is advised, the cost of treatment may be as low as $3,500
However, patients with existing heart conditionsparticularly those with a history of rapid heart rate (atrial fibrillation) or certain arrhythmiasshould discuss GLP-1 therapy with their cardiologist before starting
Patients can book video follow-ups whenever they want at no extra charge, which is unusual at the $149 monthly price point